Fuertes Abardia C, Ballesta Juan P, Cruz Esteve I, Galindo Ortego G, Marsal Mora JR, Gomez-Arbones X. Potentially inappropriate prescribing: usefulness of STOPP/START criteria version 2 in Catalonian elderly population. Semergen. 2022 Apr;48(3):163-73. doi: 10.1016/j.semerg.2021.09.005
Montserrat-Capdevila J, Godoy P, Marsal JR, Ortega M, Pifarre J, Barbe F. Comorbidity in mental health in patients diagnosed with chronic obstructive pulmonary disease. Semergen. 2020 Jan;46(1):53-9. doi: 10.1016/j.semerg.2019.08.002
Saif MW, Parikh R, Ray D, Kaye JA, Kurosky SK, Thomas K, Ramirez RA, Halfdanarson TR, Beveridge TJR, Mirakhur B, Nagar SP, Soares HP. Medical record review of transition to lanreotide following octreotide for neuroendocrine tumors. J Gastrointest Oncol. 2019 Aug;10(4):674-87. doi: 10.21037/jgo.2019.03.11
Martin SA, Coon CD, McLeod LD, Chandran A, Arnold LM. Evaluation of the fibromyalgia diagnostic screen in clinical practice. J Eval Clin Pract. 2014 Apr;20(2):158-65. doi: 10.1111/jep.12102
Brown TM, Garg S, Chandran AB, McNett M, Silverman SL, Hadker N. The impact of 'best-practice' patient care in fibromyalgia on practice economics. J Eval Clin Pract. 2012 Aug 1;18(4):793-8.